Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study

Journal of the International Neuropsychological Society

Volumn 9, Issue 5, 2003, Pages 679-689

  Grant, Igor ^a,b,c   Gonzalez, Raul ^a,d   Carey, Catherine L ^a,d   Natarajan, Loki ^a,d   Wolfson, Tanya ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabinoids; Cannabis; Cognitive effects; Marijuana; Meta analysis; Neuropsychology; THC

Indexed keywords

CANNABINOID; CANNABIS;

ADULT; CALCULATION; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CLINICAL TRIAL; COGNITION; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; HUMAN; LEARNING; MEDICAL RESEARCH; MEMORY DISORDER; MENTAL CAPACITY; META ANALYSIS; NERVOUS SYSTEM FUNCTION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW;

CANNABIS; CHRONIC DISEASE; CLINICAL TRIALS; COGNITION; HUMANS; MARIJUANA SMOKING; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS;

EID: 0038382242     PISSN: 13556177     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355617703950016     Document Type: Review

References (54)

1. Adams, K.M., Brown, G.G., & Grant, I. (1985). Analysis of covariance as a remedy for demographic mismatch of research subject groups: Some sobering simulations. Journal of Clinical and Experimental Neuropsychology, 7, 445-462.
2. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Huffman, J.W., & Layward, L. (2000). Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature, 404, 84-87.
3. Baker, D., Pryce, G., Croxford, J.L., Brown, P., Pertwee, R.G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T., & Di Marzo, V. (2001). Endocannabinoids control spasticity in a multiple sclerosis model. Faseb Journal, 15, 300-302.
4. Block, R.I. & Ghoneim, M.M. (1993). Effects of chronic marijuana use on human cognition. Psychopharmacology, 110, 219-228.
5. Carlin, A.S. & Trupin, E.W. (1977). The effect of long-term chronic marijuana use on neuropsychological functioning. International Journal of the Addictions, 12, 617-624.
6. Childers, S.R. & Breivogel, C.S. (1998). Cannabis and endogenous cannabinoid systems. Drug and Alcohol Dependence, 51, 173-187.
7. Croft, R.J., Mackay, A.J., Mills, A.T.D., & Gruzelier, J.G.H. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373-379.
8. Deif, A., El Sheshai, A., & Fawzy, R.K. (1993). Neurological, psychiatric and C.T. evaluation of chronic cannabis smokers. Journal of the Medical Research Institute, 14, 151-160.
9. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
10. Ehrenreich, H., Rinn, T., Kunert, H.J., Moeller, M.R., Poser, W., Schilling, L., Gigerenzer, G., & Hoehe, M.R. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology, 142, 295-301.
11. Fletcher, J.M., Page, J.B., Francis, D.J., Copeland, K., Naus, M.J., Davis, C.M., Morris, R., Krauskopf, D., & Satz, P. (1996 . Cognitive correlates of long-term cannabis use in Costa Rican men. Archives of General Psychiatry, 53, 1051-1057.
12. Fride, E., Ginzburg, Y., Breuer, A., Bisogno, T., Di Marzo, V., & Mechoulam, R. (2001). Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. European Journal of Pharmacology, 419, 207-214.
13. Fried, P.A. & Smith, A.M. (2001). A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology, 23, 1-11.
14. Goldschmidt, L., Day, N.L., & Richardson, G.A. (2000). Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicology and Teratology, 22, 325-336.
15. Gonzalez, R., Carey, C., & Grant, I. (2002). Nonacute (residual) neuropsychological effects of cannabis use: A qualitative analysis and systematic review. Journal of Clinical Pharmacology, 42, 48S-57S.
16. Gorter, R., Seefried, M., & Volberding, P. (1992). Dronabinol effects on weight in patients with HIV infection [Letter to the editor]. Aids, 6, p. 127.
17. Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Pelz, S., Becker, S., Kunert, H.J., Fimm, B., & Sass, H. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery and Psychiatry, 68, 719-725.
18. Grant, I., Adams, K., & Reed, R. (1979). Normal neuropsychological abilities of alcoholic men in their late thirties. American Journal of Psychiatry, 136, 1263-1269.
19. Grant, I., Adams, K.M., Carlin, A.S., Rennick, P., Judd, L.L., & Schooff, K. (1978). The collaborative neuropsychological study of polydrug abusers. Archives of General Psychiatry, 35, 1063-1074.
20. Grant, I., Atkinson, J.H., Hesselink, J.R., Kennedy, C.J., Richman, D.D., Spector, S.A., & McCutchan, J.A. (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Annals of Internal Medicine, 107, 828-836.
21. Grant, I., Heaton, R.K., McSweeny, A.J., Adams, K.M., & Timms, R.M. (1982). Neuropsychological findings in hypoxemic chronic obstructive pulmonary disease. Archives of Internal Medicine, 142, 1470-1476.
22. Grant, I. & Mohns, L. (1975). Chronic cerebral effects of alcohol and drug abuse. International Journal of the Addictions, 10, 883-920.
23. Grant, I., Rochford, J., Fleming, T., & Stunkard, A. (1973). A neuropsychological assessment of the effects of moderate marihuana use. Journal of Nervous and Mental Disease, 156, 278-280.
24. Hamil, W.L. (1996). Auditory learning and memory performance among veterans with a history of stimulant abuse. Dissertation Abstracts International: Section B: The Sciences and Engineering, 56, 5806.
25. Hao S., Avraham, Y., Mechoulam, R., & Berry, E.M. (2000). Low dose anandamide affects food intake, cognitive function, neuro-transmitter and corticosterone levels in diet-restricted mice. European Journal of Pharmacology, 392, 147-156.
26. Heaton, R.K., Grant, I., Anthony, W.Z., & Lehman, R.A. (1981). A comparison of clinical and automated interpretation of the Halstead-Reitan Battery. Journal of Clinical Neuropsychology, 3, 121-141.
27. Heaton, R.K., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, J.H., McCutchan, J.A., Taylor, M.J., Kelly, M.D., Ellis, R.J., Wolfson, T., Velin, R., Marcotte, T.D., Hesselink, J.R., Jernigan, T.L., Chandler, J., Wallace, M., Abramson, I., & the HNRC Group. (1995). The HNRC 500-Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231-251.
28. Heaton, R.K., Grant, I., & Matthews, C.G. (1991). Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources, Inc.
29. Hedges, L.V. & Olkin, I. (1985). Statistical methods for meta-analysis. Orlando, FL: Academic Press.
30. Herkenham, M. (1992). Cannabinoid receptor localization in brain: Relationship to motor and reward systems. Annals of the New York Academy of Sciences, 654, 19-32.
31. Herkenham, M., Lynn, A.B., de Costa, B.R., & Richfield, E.K. (1991a). Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Research, 547, 267-274.
32. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R., & Rice, K.C. (1991b). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience, 11, 563-583.
33. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., & Rice, K.C. (1990). Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America, 87, 1932-1936.
34. Howlett, A.C., Bidaut-Russell, M., Devane, W.A., Melvin, L.S., Johnson, M.R., & Herkenham, M. (1990). The cannabinoid receptor: Biochemical, anatomical and behavioral characterization. Trends in Neurosciences, 13, 420-423.
35. Institute of Medicine. (1999). Marijuana and medicine: Assessing the science base. Washington, DC: Author.
36. Kaminski, N.E., Abood, M.E., Kessler, F.K., Martin, B.R., & Schatz, A.R. (1992). Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Molecular Pharmacology, 42, 736-742.
37. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., & Bonner, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
38. Munro, S., Thomas, K.L., & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
39. Nelson, K., Walsh, D., Deeter, P., & Sheehan, F. (1994). A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Journal of Palliative Care, 10, 14-18.
40. Noyes, R., Brunk, S.F., Baram, D.A., & Canter, A. (1975). Analgesic effect of delta-9-tetrahydrocannabinol. Journal of Clinical Pharmacology, 15, 139-143.
41. Pertwee, R. (1993). The evidence for the existence of cannabinoid receptors. General Pharmacology, 24, 811-824.
42. Pertwee, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacology and Therapeutics, 74, 129-180.
43. Plasse, T.F., Gorter, R.W., Krasnow, S.H., Lane, M., Shepard, K.V., & Wadleigh, R.G. (1991). Recent clinical experience with dronabinol. Pharmacology, Biochemistry and Behavior, 40, 695-700.
44. Pope, H.G., Gruber, A.J., Hudson, J.I., Huestis, M.A., & Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58, 909-915.
45. Pope, H.G., Gruber, A.J., & Yurgelun-Todd, D. (1995). The residual neuropsychological effects of cannabis - The current status of research. Drug and Alcohol Dependence, 38, 25-34.
46. Pope, H.G. & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 275, 521-527.
47. Rochford, J., Grant, I., & LaVigne, G. (1977). Medical students and drugs: Further neuropsychological and use pattern considerations. International Journal of the Addictions, 12, 1057-1065.
48. Rodgers, J. (2000). Cognitive performance amongst recreational users of "ecstasy." Psychopharmacology, 151, 19-24.
49. Sanudo-Pena, M.C. & Walker, J.M. (1997). Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat. Journal of Neurophysiology, 77, 1635-1638.
50. Solowij, N. (1995). Do cognitive impairments recover following cessation of cannabis use? Life Sciences, 56, 2119-2126.
51. Solowij, N. (1998). Cannabis and cognitive functioning. New York: Cambridge University Press.
52. Solowij, N., Stephens, R.S., Roffman, R.A., Babor, T., Kadden, R., Miller, M., Christiansen, K., McRee, B., & Vendetti, J. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287, 1123-1131.
53. US National Institute of Health. (1997). Report on the medical uses of marijuana. Bethesda, MD.
54. Wig, N.N. & Varma, V.K. (1977). Patterns of long-term heavy cannabis use in North India and its effects on cognitive functions: A preliminary report. Drug and Alcohol Dependence, 2, 211-219.